A doctor’s warning and confirmation from the HAS
In an article published in the *Daily Mail*, general practitioner Philippa Kaye sounds the alarm regarding the long-term use of proton pump inhibitors (PPIs)—a class of drugs that includes omeprazole, lansoprazole, and esomeprazole. She warns of potential risks that, beyond a certain duration, could outweigh the expected benefits, such as nutritional deficiencies and kidney issues.
Her view is echoed in France, where the French National Authority for Health (HAS) has recommended since 2022 that the duration of these treatments be limited
